SIGN UP

November 1, 2022 06:59 AM EDTUpdated 07:12 AM

Drew Armstrong is coming to Endpoints(!) And there are some more surprises to come

There are a few big days to recall in the six-year history of Endpoints News. (Actually, six years, four months and 12 days, but who …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE

TRENDING NOW

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

sponsored

Are programs with compounded GLP-1s safe for your population?